Webinar replay

The Art & Science of Biopharma Due Diligence: Lessons from Eli Lilly

Discover best practices for successfully managing the due diligence process from Eli Lilly.

During this post, our panelists will share their proven strategies and techniques, highlight key challenges, and discuss how to negotiate the rapidly changing landscape while maintaining a robust due diligence process.
Watch this replay to get expert insights from our panelists:
Mike-Myers
Mike Myers
Senior Director, Global External R&D, Due Diligence
Eli Lilly
Scott-Simmons
Scott Simmons
Consultant, Due Diligence
Eli Lilly
Shanker circle
Shanker Shrestha
Senior Solutions Consultant
Inova

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.